Antibiotiques

A fluoroquinolone antibiotic which inhibits nucleic acid synthesis by targeting the DNA gyrase and topoisomerase IV. This second-generation fluoroquinolone has a broad spectrum of action and is more effective against Gram-negative bacteria.

Broad spectrum, long-acting and lipid soluble tetracycline antibody

Ketolide; binds bacterial ribosomes and inhibits translation

Dirithromycin is a macrolide glycopeptide antibiotic with action on bacterial protein synthesis inhibition and is used for treating respiratory, skin, and other bacterial infections.

Amphotericin B is a macrocycle antibiotic first isolated from Streptomyces nodosus. Its antifungal activity is exerted by interacting with the fungal membrane, mainly ergosterol, and inducing pore formation. The increase in membrane permeability causes loss of ions and cell death. The C-2’ hydroxyl residue of the mycosamine carbohydrate moiety in the structure seems to have a major role in binding to ergosterol. It is used in cell culture to prevent growth of microbial contaminants, such as yeast and fungi. It is recommended by the WHO and CDC as an antifungal component for VTM at a concentration of 250ug/ml.

Polypeptide antibiotic used as a feed additive

Midecamycin is a macrolide antibiotic with action on bacterial protein synthesis by binding to the 50S ribosomal subunit and is used for treating respiratory tract and skin infections.

Delamanid is a second-line antimicrobial agent, which is a synthetic derivative of the nitro-dihydro-imidazooxazole compound. Delamanid originates from a laboratory synthesis designed to target and inhibit specific components of bacterial cell wall synthesis. The mode of action involves the inhibition of mycolic acid synthesis, which is critical for the maintenance and construction of the cell wall in Mycobacterium tuberculosis. This inhibition disrupts bacterial cell wall integrity, ultimately exerting a bactericidal effect against actively replicating and dormant mycobacterial cells.

Albomitomycin A is an antibiotic compound, which is derived from the fermentation of specific Streptomyces species. This compound exhibits a unique mode of action by inhibiting protein synthesis in bacterial cells, specifically targeting the 30S ribosomal subunit. This interference with ribosomal function ultimately disrupts the production of essential proteins, leading to bacterial cell death.

Inhibitor of cell wall biogenesis; glycopeptide antibiotic

Hygromycin B binds near the A site of 16S rRNA and induces errors in the code by inhibition of translocation of peptydil-tRNA, however to a lesser extent compared to other aminoglycosides. Hygromycin B is efficient against bacteria, fungi and other eukaryotic cells, but more often used for the selection of eukaryotic cells including yeasts, such as, P. pastoris and S. cerevisiae, and mammalian cell lines, such as, CHO.

Cefotaxime sodium is a broad-spectrum cephalosporin antibiotic, which is a semisynthetic derivative of cephalosporin C obtained from the mold Acremonium. This compound functions by inhibiting bacterial cell wall synthesis, which it achieves through binding to and deactivating penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. This action prevents the cross-linking of peptidoglycan chains, leading to cell lysis and bacterial death, primarily affecting rapidly dividing cells.

Inhibitor of cell-wall synthesis; carbapenem class

Ceftriaxone is a broad-spectrum cephalosporin antibiotic that is used for the treatment of bacterial infections in different locations such as the skin, soft tissue and respiratory tract. This drug works by inhibiting mucopeptide synthesis in the bacterial cell wall. As a result, bacteria will produce defective cell walls leading to cell death.

Chlorotetracycline monohydrochloride is an antibiotic compound specifically designed for culture media use. It is derived from a naturally occurring tetracycline produced by the bacterium *Streptomyces aureofaciens*. As a broad-spectrum antibiotic, chlorotetracycline functions by inhibiting protein synthesis in susceptible bacteria. It binds to the 30S subunit of the bacterial ribosome, blocking the attachment of aminoacyl-tRNA to the ribosomal acceptor site, which effectively halts translational elongation.

Anthracycline antibiotic with potent anti-tumoral activity. The compound interferes with DNA replication and RNA transcription since it intercalates between the base pairs of nucleic acids. It also inhibits the topoisomerase II, proteasome and generates free radicals, which leads to cell death of treated cells. Moreover, daunorubicin triggers apoptosis trough the stimulation of ceramide synthesis. It has been used as chemotherapy agent for the treatment of myeloid leukaemia (AML) and acute lymphocytic leukaemia (ALL).

Cefditoren acid sodium is an antibacterial agent that belongs to the class of third-generation cephalosporins, which is derived from Acremonium fungus and produced through chemical synthesis. This compound acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It achieves this by binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall. The interruption of peptidoglycan synthesis in the cell wall is crucial for maintaining bacterial cell integrity, and its inhibition results in the bactericidal activity of cefditoren acid sodium. It is effective against a range of Gram-positive and Gram-negative bacteria. The key applications of this compound include the treatment of bacterial infections such as respiratory tract infections, skin infections, and other conditions caused by susceptible bacteria. Its spectrum of activity and pharmacokinetic properties make it suitable for situations where third-generation cephalosporins are indicated. Understanding the specific interaction with PBPs and the resistance mechanisms is crucial for optimizing its clinical use and managing antibiotic resistance.

A fluoroquinolone antibiotic which inhibits nucleic acid synthesis by targeting the DNA gyrase and topoisomerase IV. This second-generation fluoroquinolone has a broad spectrum of action and is more effective against Gram-negative bacteria.